“A Multi-Center, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability and Pharmacokinetics, and Explore the Efficacy of Sofpironium Bromide Gel, 15% Applied Topically to Children Adolescents, 9-16 Years, With Primary Axillary Hyperhidrosis”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s116, https://doi.org/10.25251/skin.4.supp.116.